Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Liver Fibroses: early-phase trial registry
1 of 3 indexed Liver Fibroses trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Liver Fibroses: 3 US clinical trials tracked, 1 recruiting.
Liver Fibroses is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Raymond Chung, running 1 of these trials.
Enrollment posture brief
Registry condition liver-fibroses
OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Liver Fibroses lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Liver Fibroses on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Liver Fibroses is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Raymond Chung
NCT05028829
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
Brigham and Women's Hospital
NCT04820036
Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) Elastography
University of Michigan
NCT03382119
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Liver Fibroses records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Liver Fibroses trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Liver Fibroses page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Liver Fibroses trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Raymond Chung sponsors the most Liver Fibroses trials on record, review their full trial history before evaluating a specific study. See Raymond Chung's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Liver Fibroses condition card totals 3 registered trials; most-linked intervention Ultrasound with backscatter imaging; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.